You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis
2 October 2026 - US healthcare company Johnson & Johnson (NYSE: JNJ) on Friday announced the release of two-year Phase 3 results from ICONIC-TOTAL assessing ICOTYDE (icotrokinra) in adults and adolescents with moderate high-impact plaque psoriasi...
2 October 2026 - Avimer Bio, a California-based biotechnology company, in collaboration with structural biologists at the Spanish National Cancer Research Centre (CNIO), announced on Thursday a new publication in the Journal of the American Chemical ...
2 October 2026 - Cerapedics Inc., a US-based, commercial-stage musculoskeletal company involved in bone repair, announced on Thursday that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status ...
2 October 2026 - Abogen Biosciences, a China-based clinical-stage biotechnology group, announced on Friday that it has entered into a licensing and option agreement with Swiss pharmaceutical company Novartis to advance RNA-encoded therapeutics.The ag...
1 October 2026 - Swedish pharmaceutical company Immedica Pharma AB, backed by investment firms KKR & Co. Inc. (NYSE: KKR) and Impilo, announced on Thursday that its partner, Spanish biopharmaceutical company PharmaMar, has secured MHRA approval f...
1 October 2026 - Greentech company AFYREN (Euronext Paris:ALAFY) said on Thursday that it its 100% bio-based, COSMOS-certified propionic acid has enabled the global launch of Esse Barrier Rescue, developed with South Africa-based microbiome skincare ...
30 September 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) revealed on Wednesday that it has achieved positive 48-week Phase 2b results for EloraTZP, its investigational combination of eloralintide and tirzepatide, showing greater weight ...